Comparison of ClinSurv HIV with other ongoing clinical HIV cohort

Comparison of ClinSurv HIV with other ongoing clinical HIV cohort studies suggests that the ClinSurv HIV data might play a more important role in the future in complementing HIV research in European countries Selleckchem PARP inhibitor with concentrated HIV

epidemics [7–9]. Close collaboration with European HIV drug resistance networks [the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) and the Collaboration of Observational HIV Epidemiological Research Europe (COHERE)] is already ongoing or planned for the near future. After almost 10 years of data collection, the German national ClinSurv HIV cohort study has evolved to become a valuable and effective tool for clinical surveillance. Its database is stored and managed at the Unit for HIV/AIDS, STI and Blood-Borne Infections of the Department of Infectious Disease Epidemiology of the RKI in Berlin. It is hoped that this cohort study will make significant contributions to answering epidemiological and clinical research questions in the future in countries such as Germany with concentrated HIV

epidemics. ClinSurv HIV is interested in further national and international research co-operation in the area of clinical HIV epidemiology. Additional information about ClinSurv HIV is provided on the homepage of the RKI [25]. PD-1/PD-L1 targets Berlin: Charité, Universitätsmedizin Berlin, Campus Rudolph Virchow (Dr F Bergmann and Prof. Dr N Suttorp); Vivantes-Klinikum, Auguste-Viktoria-Krankenhaus (Priv.-Doz. Dr K Arasteh)*. Bochum: Ruhr Universität Bochum, St Joseph Hospital (Prof. Dr N Brockmeier)*. Bonn: Rheinische Friedrich-Wilhelm Universität Bonn (Prof. Dr J Rockstroh). Düsseldorf: Universitätsklinikum Düsseldorf (Dr S Reuter and Prof. Dr D Häusinger). Essen: Universitätsklinikum Essen, Klinik für Dermatologie (Dr S Esser)*. Hamburg: Institut für interdisziplinäre Infektiologie oxyclozanide (ifi) (Prof. Dr A Plettenberg); Bernhard Nocht-Institut (Prof. Dr G-D Burchard)†; Universitätsklinikum Hamburg-Eppendorf (Priv.-Doz.

Dr J van Lunzen); Infektionsmedizinisches Centrum Hamburg (ICH), ICH Study Center (Dr K Schewe, Dr L Weitner, Dr A Adam, Dr H Gellermann, Dr S Fenske, Dr T Buhk, Prof. Dr H-J Stellbrink and Priv.-Doz. Dr C Hoffmann). Hannover: Medizinische Hochschule Hannover (Prof. Dr M Stoll and Prof. Dr RE Schmidt). Kiel: Universitätsklinikum Kiel (Prof. Dr H Horst). Köln: Universität zu Köln (Dr T Kümmerle and Prof. Dr G Fätkenheuer). München: Ludwig-Maximilians-Universität München (Prof. Dr J Bogner). Rostock: Universitätsklinikum Rostock (Dr C Fritsche and Prof. Dr EC Reisinger). All persons listed are members of the ClinSurv HIV Study Group. *The inclusion of data from these three treatment centres in the ClinSurv HIV cohort is currently in preparation. Since 2002 this centre has not actively contributed patient data; however, previously reported case events remain within the observational database. The authors are grateful to all collaborative treatment centres listed in the Appendix.

Comments are closed.